These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 79036)

  • 21. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
    The Canadian Cooperative Stroke Study Group
    Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of platelets in transient ischemic attacks and cerebral vascular accidents.
    Barnett HJ
    Adv Exp Med Biol; 1978; 102():257-63. PubMed ID: 685753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of aspirin and sulfinpyrazone in patients with TIA.
    Candelise L; Landi G; Perrone P; Bracchi M; Brambilla G
    Stroke; 1982; 13(2):175-9. PubMed ID: 7039004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ticlopidine hydrochloride and prevention of stroke.
    Macko R
    West J Med; 1993 Aug; 159(2):182. PubMed ID: 8212686
    [No Abstract]   [Full Text] [Related]  

  • 25. Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
    Millikan CH
    Trans Am Neurol Assoc; 1973; 98():206-18. PubMed ID: 4784937
    [No Abstract]   [Full Text] [Related]  

  • 26. The pathophysiology of transient cerebral ischemic attacks.
    Barnett HJ
    Med Clin North Am; 1979 Jul; 63(4):649-79. PubMed ID: 381803
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspirin for prevention of myocardial infarction and stroke.
    Med Lett Drugs Ther; 1989 Aug; 31(799):77-9. PubMed ID: 2671622
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
    Inzitari D; Fratiglioni L; Baldereschi M; Candelise L; Anzalone N; Bonatti ML; Prencipe M; Gandolfo C; Mamoli A; Rasura M
    Epidemiol Prev; 1990 Jun; 12(43):6-11. PubMed ID: 2149110
    [No Abstract]   [Full Text] [Related]  

  • 29. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
    Bousser MG
    Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebrovascular disease.
    Warlow CP
    Clin Haematol; 1981 Jun; 10(2):631-51. PubMed ID: 7032789
    [No Abstract]   [Full Text] [Related]  

  • 31. [European atrial fibrillation trial (EAFT). Secondary prevention with anticoagulants and aspirin in patients with non-valvular atrial fibrillation having suffered a transient ischemic attack or a regressive vascular accident].
    Besson G; Bogousslavsky J
    Rev Med Suisse Romande; 1991 Jan; 111(1):49-55. PubMed ID: 2006364
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical prevention of ischemic stroke.
    Barnett HJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():247-55. PubMed ID: 3159208
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspirin for transient ischemic attacks.
    Med Lett Drugs Ther; 1980 Aug; 22(17):71-2. PubMed ID: 6995822
    [No Abstract]   [Full Text] [Related]  

  • 34. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 35. One aspirin can't prevent a stroke but can prevent a major vascular event.
    Perry MO
    JAMA; 1987 Aug; 258(6):779. PubMed ID: 3613000
    [No Abstract]   [Full Text] [Related]  

  • 36. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Reply.
    Barnett HJ; Gent M; Sackett DL; Taylor DW
    Ann Neurol; 1979 Jun; 5(6):599-601. PubMed ID: 382979
    [No Abstract]   [Full Text] [Related]  

  • 37. Aspirin and stroke prevention: how much?
    Toffol GJ
    J Am Osteopath Assoc; 1990 May; 90(5):435-7. PubMed ID: 2191940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 39. Stroke prevention: the emerging strategies.
    McCrory DC; Matchar DB
    Hosp Pract (1995); 1996 Mar; 31(3):123-8,131-2,134. PubMed ID: 8595997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.